A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects

NCT02113020 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Clinical Pharmacology

Interventions

DRUG: TAK-233
DRUG: Placebo

Sponsor

Takeda